Stratasys Ltd
SSYS
ISIN IL0011267213 / Valor 20156046
Stratasys Ltd
UMushroom community rating:
About company
Stratasys Ltd is a global leader in additive manufacturing or 3D printing technology, with a focus on the development, manufacturing, and sale of 3D printers and materials for prototyping and production. The company's collaboration with Siemens Healthineers on a research project to develop advanced solutions for medical imaging phantoms for computed tomography (CT) imaging highlights Stratasys's commitment to innovation and its application in healthcare. This partnership aims to enhance the capabilities of CT imaging, demonstrating Stratasys's involvement in projects that have the potential to significantly impact medical diagnostics and treatment planning. While the company operates across various sectors, this specific initiative underscores its strategic move towards leveraging its 3D printing technologies to contribute to advancements in the medical field, particularly in improving the accuracy and efficacy of diagnostic imaging.
Summarized from source with an LLMView SourceSector: IndustrialsLatest Results (10.11.2025):
Stratasys Ltd. reported its Second Quarter 2025 financial results, demonstrating resilience in a challenging macroeconomic environment. The company recorded revenue of $138.1 million, nearly flat compared to the prior year, with a GAAP net loss of $16.7 million (or $0.20 per diluted share) and a non-GAAP net income of $2.2 million (or $0.03 per diluted share). Notably, Adjusted EBITDA rose to $6.1 million from $2.3 million, underscoring the strength of its recurring revenue streams. Additionally, Stratasys Ltd. ended the quarter with a robust cash position of $254.6 million and no debt, further supporting its strategy for innovation and growth.
Revenue Stability and Cash Strength
In the Second Quarter 2025, Stratasys Ltd. maintained revenue consistency at $138.1 million versus $138.0 million in the comparable quarter last year, and bolstered its balance sheet with $254.6 million in cash, equivalents, and short-term deposits alongside zero debt.
Improved Profitability and Operational Metrics
The company achieved a significant improvement in its operational performance, with Adjusted EBITDA increasing to $6.1 million from $2.3 million. Despite a GAAP net loss of $16.7 million, the shift to non-GAAP measurements revealed a move to net income of $2.2 million, highlighting effective cost management and strategic operational efficiencies during the quarter.
Forward-Looking Outlook
Looking ahead, Stratasys Ltd. has updated its 2025 outlook with cautious optimism. The guidance anticipates full-year revenue in the range of $550–$560 million and outlines progressive improvements in margin performance and operating efficiencies, positioning the company to capitalize on emerging opportunities while navigating ongoing macroeconomic headwinds.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
727 M
Market cap (USD)
846,364
Daily traded volume (Shares)
9.03 / 8.77
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
